714 related articles for article (PubMed ID: 32085772)
1. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Ma X; Sun Y; Cheng Y; Shen H; Gao F; Qi J; Yang L; Wang Z; Shi D; Liu Y; Liu X; Zhou Y
Lipids Health Dis; 2020 Nov; 19(1):240. PubMed ID: 33198752
[TBL] [Abstract][Full Text] [Related]
3. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus.
Fu L; Zhou Y; Sun J; Zhu Z; Xing Z; Zhou S; Wang Y; Tai S
Cardiovasc Diabetol; 2021 Oct; 20(1):201. PubMed ID: 34610830
[TBL] [Abstract][Full Text] [Related]
4. The Atherogenic Index of Plasma: A Powerful and Reliable Predictor for Coronary Artery Disease in Patients With Type 2 Diabetes.
Zhou K; Qin Z; Tian J; Cui K; Yan Y; Lyu S
Angiology; 2021 Nov; 72(10):934-941. PubMed ID: 33949211
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of atherogenic index of plasma for cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention with LDL-C below 1.8mmol/L.
Wang Y; Wang S; Sun S; Li F; Zhao W; Yang H; Wu X
Cardiovasc Diabetol; 2023 Jun; 22(1):150. PubMed ID: 37365588
[TBL] [Abstract][Full Text] [Related]
6. High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study.
He J; Bian X; Song C; Zhang R; Yuan S; Yin D; Dou K
Cardiovasc Diabetol; 2022 Aug; 21(1):156. PubMed ID: 35964050
[TBL] [Abstract][Full Text] [Related]
7. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
8. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort.
Wang P; Yuan D; Zhang C; Zhu P; Jia S; Song Y; Tang X; Xu J; Li T; Zeng G; Zhao X; Yang Y; Xu B; Gao R; Yuan J
Cardiovasc Diabetol; 2022 Mar; 21(1):46. PubMed ID: 35313877
[TBL] [Abstract][Full Text] [Related]
9. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
Wang H; Ning X; Zhu C; Yin D; Feng L; Xu B; Guan C; Dou K
Catheter Cardiovasc Interv; 2019 Feb; 93(S1):787-792. PubMed ID: 30618111
[TBL] [Abstract][Full Text] [Related]
11. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
[TBL] [Abstract][Full Text] [Related]
12. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention.
Xu N; Tang XF; Yao Y; Jia SD; Liu Y; Zhao XY; Chen J; Gao Z; Yang YJ; Gao RL; Xu B; Yuan JQ
Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):265-273. PubMed ID: 31740238
[TBL] [Abstract][Full Text] [Related]
14. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
[No Abstract] [Full Text] [Related]
15. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
Cardiovasc Diabetol; 2021 Sep; 20(1):190. PubMed ID: 34537077
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus.
Zhu XW; Deng FY; Lei SF
Prim Care Diabetes; 2015 Feb; 9(1):60-7. PubMed ID: 24810146
[TBL] [Abstract][Full Text] [Related]
17. The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention.
Yang J; Tang YD; Zheng Y; Li C; Zhou Q; Gao J; Meng X; Zhang K; Wang W; Shao C
Front Endocrinol (Lausanne); 2021; 12():710240. PubMed ID: 34489866
[TBL] [Abstract][Full Text] [Related]
18. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
[TBL] [Abstract][Full Text] [Related]
19. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
[TBL] [Abstract][Full Text] [Related]
20. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]